Johnson Financial Group, LLC Abb Vie Inc. Transaction History

Johnson Financial Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $172,437 - $219,224	-1,253 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $165,370 - $205,178	1,253 New	1,253 $203,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $269,127 - $331,906	-3,457 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $318,078 - $425,936	3,457 New	3,457 $327,000

4,108

1.28B

16.7M

15M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $378B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Johnson Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Johnson Financial Group, LLC with notifications on news.